Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C

摘要

Background & Aims: Therapies that slow fibrosis progression in chronic liver disease are needed. Animal models have demonstrated that statins prevent the progression of hepatic fibrosis, but human data is lacking so far. We evaluated the association between statins and fibrosis progression in the HALT-C trial cohort.